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Abstract
The recent discovery of the potent regulatory nature of microRNAs (miRNAs), a relatively new 
class of approximately 22 nucleotide RNAs, has made them a primary focus in today’s 
biochemical and medical research. The relationship between miRNA expression patterns and the 
onset of cancer, as well as other diseases, has glimpsed the potential of miRNAs as disease 
biomarkers or drug targets, making them a primary research focus. Their promising future in 
medicine is hinged upon improving our scientific understanding of their intricate regulatory 
mechanisms. In the realm of analytical chemistry, the main challenge associated with miRNA is its 
detection. Their extremely small size and low cellular concentration poses many challenges for 
achieving reliable results. Current reviews in this area have focused on adaptations to microarray, 
PCR, and Northern blotting procedures to make them suitable for miRNA detection. While these 
are extremely powerful methods and accepted as the current standards, they are typically very 
laborious, semi-quantitative, and often require expensive imaging equipment and/or radioactive/
toxic labels. This review aims to highlight emerging techniques in miRNA detection and 
quantification that exhibit superior flexibility and adaptability as well as matched or increased 
sensitivity in comparison to the current standards. Specifically, this review will cover colorimetric, 
fluorescence, bioluminescence, enzyme, and electrochemical based methods, which drastically 
reduce procedural complexity and overall expense of operation thereby increasing the accessibility 
of this field of research. The methods are presented and discussed as to their improvements over 
current standard methods as well as their potential complications preventing acceptance as 
standard procedures. These new methods have addressed the many of the problems associated with 
miRNA detection through the employment of enzyme-based signal amplification, enhanced 
hybridization conditions using PNA capture probes, highly sensitive and flexible forms of 
spectroscopy, and extremely responsive electrocatalytic nanosystems, among other approaches.
Introduction
The inadvertent discovery of the microRNA (miRNA) lin-4 in Caenorhabditis elegans 
(1993) by Lee and colleagues [1] was initially thought to be a sporadic anomaly of nature. 
*Corresponding author: sdeo@iupui.edu; Phone: (317) 278-7532; Fax: (317) 274-4701, Mail proofs to: Sapna Deo, 402 N Blackford 
Street, LD 326, Indianapolis, IN 46202-3274. 
Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our 
customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of 
the resulting proof before it is published in its final citable form. Please note that during the production process errors may be 
discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
HHS Public Access
Author manuscript
Anal Biochem. Author manuscript; available in PMC 2016 April 12.
Published in final edited form as:
Anal Biochem. 2009 April 1; 387(1): 1–12. doi:10.1016/j.ab.2009.01.011.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
However, the discovery of the miRNA let-7 and its ability to regulate lin-14 (a gene which 
controls the developmental stages of C. elegans) by Ruvkun and colleagues [2] just under a 
decade later (2000), set this new class of regulatory nucleic acids as the primary focus of a 
recent explosion of research. Since then, miRNAs have been studied at great length, and 
been found to control such functions as cell proliferation, apoptosis, and fat metabolism in 
humans; the distinct larval stages and neuronal patterning in developing nematodes; and leaf 
and flower growth in plants. [3] These tiny, approximately 22 nucleotide sequences achieve 
this incredible array of regulatory functions through the degradation and translational 
repression of messenger RNA (mRNA). [4]
The coding sequences for miRNAs are typically found in intergenic regions (spaces between 
genes in which there are few to no sequences coding for proteins) or within the introns (in 
eukaryotes, non-coding sequences which interrupt genes and are removed through mRNA 
processing before translation occurs) of protein-coding genes. Their initial template, known 
as primary miRNA (pri-miRNA) is transcribed by RNA polymerase II. These pri-miRNAs 
can be thousands of nucleotides long, and typically contain a variety of stem-loop moieties 
and a hairpin structure, making it pseudo-double-stranded. The miRNA sequence is further 
capped and polyadenylated in the nucleus before the RNase-III enzymes Drosha and Pasha 
excise a 60–80 nucleotide intermediate known as precursor miRNA (pre-miRNA). 
Following exportation to the cytoplasm by the Exportin-5 factor, the pre-miRNA is further 
cleaved into an 18–24 double-stranded oligonucleotide by the RNase-III enzyme Dicer. One 
of these strands is incorporated into a protein complex known as the RNA-induced silencing 
complex (RISC) and is now in the “mature” form capable of post-transcriptional regulation 
of mRNAs (Figure 1). [5; 6] This capacity for regulation allocates the mature form as the 
typical target for most miRNA assays.
According to miRBase (http://microrna.sanger.ac.uk/), a collective registry of currently 
known miRNA sequences and targets hosted by the Sanger Institute, there are currently 695 
recognized miRNA sequences in the Homo sapiens genome, and the number is constantly 
growing as new sequences are discovered. [7] The rapid regulatory ability of these miRNAs 
has drastic implications on a cell’s health, especially when their expression pattern becomes 
erratic, and for this reason they are becoming an increasingly popular focus for research in 
the medical realm. Recent discoveries have shown that miRNA expression patterns are 
drastically altered in cancer cell lines, such that proliferation is up-regulated and apoptosis is 
considerably, if not entirely, repressed. [6; 8] Cellular miRNA expression levels can 
therefore be used as biomarkers for the onset of disease states. [9; 10] It has been shown that 
many miRNA sequences are oncogenic, and that their deregulation can force cells into 
tumorous states. [11; 12; 13] The causative nature of these types of disease factor miRNAs 
distinguishes them as possible drug targets. [14] Another major focus in medicinal research 
is centered on the possible usage of miRNAs in gene therapy for genetic disorders. If these 
miRNAs could be designed to target the mRNA of disease related genes, the phenotypic 
expression could be successfully silenced, preventing the onset of the diseased state. [8]
The characterization of such disease states requires accurate expression profiling of these 
miRNA sequences. The current standard methods, such as Northern blotting, microarrays, or 
RT-PCR, are laborious, semi-quantitative, and require expensive imaging equipment or 
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radioactive/toxic labels. These requirements tend to make this area of research less 
accessible to academic or non-commercial environments. Current reviews in this area have 
introduced novel developments used to overcome the difficulties associated with miRNA 
detection using microarray platforms, and introduced some of the modifications made to 
PCR and Northern blotting procedures to permit their extension to miRNA detection. [15; 
16] This review aims to explore emerging techniques in miRNA detection and 
quantification, which are not associated with the current standard PCR, Northern blotting, or 
microarray methods. These new assays demonstrate superior flexibility and adaptability as 
well as matched or increased sensitivity in comparison to the current standards. Additionally, 
their approaches drastically reduce the procedural complexity and overall expense of 
operation thereby increasing the accessibility of this field of research.
Colorimetric-Based miRNA Detection
Colorimetric-based detection methods are attractive because the setups are relatively simple. 
Most colorimetric experiments can be carried out with inexpensive imaging equipment such 
as a CCD camera and a personal computer for analysis. While these aspects are beneficial 
because they drastically reduce the cost and procedural complexity of the setup, colorimetric 
methods sometimes suffer from lower detection limits. This is not always the case, however, 
and there are many colorimetric assays which rival their fluorescent counterparts.
A simple solid phase assay developed by Yang and colleagues utilized adjacent 
complementary probes to capture a target sequence and register a corresponding fluorescent 
signal (Figure 2). [17] The capture probe is biotinylated, and the signal probe is directly 
conjugated to a gold nanoparticle via the chemical method developed by Mirkin and 
colleagues. [18] In this method, the oligonucleotide probes, modified with gold-reactive 
terminal thiols, are mixed with gold nanoparticles yielding the semi-spontaneous assembly 
of the probe. Each probe is complementary to half the target sequence. The two probes and 
miRNA target-containing mixture are combined under optimal conditions to form a 
hybridization complex. This complex may then be immobilized onto a streptavidin coated 
microtiter plate and silver enhanced to amplify the colorimetric signal from the absorbed 
gold nanoparticles. Silver enhancement is a reduction process which converts silver ions into 
their metallic form and ultimately coats the gold nanoparticles. The process is catalyzed by 
the gold nanoparticle, and is carried out by adding a solution of hydroquinone and silver 
nitrate in an acidic (pH 3.8) citrate buffer to the probe and incubating at room temperature. 
The miRNA is then quantified by measuring absorbance using a simple well plate reader.
A calibration study for the assay developed by Yang and colleagues was done by varying 
miR122a concentrations from 1 fM to 1 nM. The lower detection limit of this assay was 
found to be 10 fM for the miR-122a sequence extracted from mouse liver and brain tissues. 
The nanoparticle assay was also tested against a TaqMan miRNA RT-PCR assay. While the 
R2 value of this comparison was acceptable, 0.9249, the RT-PCR method has a slightly 
lower detection limit. Additionally, a specificity study was performed using probe sets 
containing single nucleotide polymorphisms. One set of miR-122a probes contained one 
point mutation each. The point mutation was detectable when it fell within the confines of 
the signal probe (gold-nanoparticle) sequence. In other words, mutations made in the capture 
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probe sequence did not produce as noticeable a signal reduction as those made in the signal 
probe sequence. The assay was also performed using probes for the miR-128 sequence. The 
miR-128 target was only detected in mouse brain tissues, whereas the miR-122a target was 
only detected in liver tissues. The goal of these experimental variations was to show the 
relatively low susceptibility of the probe system to non-specific binding and/or cross-
hybridization.
The gold-nanoparticle-based method discussed above is attractive in that it is relatively 
inexpensive and can be completed in a short time frame (approximately 1 h hybridization 
time). The high selectivity of this assay is hinged upon the optimization of the hybridization 
and rinse temperatures for each miRNA sequence targeted. When held in comparison to the 
amount of optimization required for a blotting assay, the adaptations required for this assay 
are quite manageable. There is currently no explanation as to why point mutations can only 
be detected in the signal probe domain. The authors suggest that this inconvenience may be 
avoided by using two sets of signal probes and swapping the molecules at the termini. This 
would require two assays to be performed per sample, but any discrepancy between the two 
assays would be indicative of a mutation and its general location on the target.
Fluorescence-Based miRNA Detection
Fluorescence is an extremely sensitive and adaptable form of spectroscopy, and for this 
reason it is frequently used for direct, in situ assays. There are many different types of 
fluorescent reporters available for these applications, from organic dyes to fluorescent 
proteins to inorganic nanostructures. Perhaps the most prominent fluorescent reporters in 
current research are inorganic nanostructures such as quantum dots or gold nanoparticles. 
These structures have outstanding fluorescent properties, such as broad excitation ranges 
complimented by extremely sharp emission bands, affording superior spectral resolution. 
Their high quantum yield makes them appealing for direct detection applications, removing 
the need for sample enrichment and amplification, which can be exceedingly inconvenient, 
and thereby reducing the procedural complexity, making the prescribed technique more 
versatile and accessible.
In a method developed by Neely and colleagues, a dual probe labeling system was used in 
conjunction with fluorescence correlation spectroscopy (FCS) to count and quantify single 
molecules of miRNA. [19] Two locked nucleic acid (LNA) DNA probes, each 
complementary to one half of the target sequence, were modified with fluorescent tags, one 
with Oyster 556 (green probe) and one with Oyster 656 (red probe). A Trilogy five laser 
(one DPSS 488 nm, one DPSS 532 nm, two HeNe 633 nm, and one 750 nm diode) confocal 
fluorescence detector capable of four color detection in a single microfluidic stream was 
used to acquire the data. The microfluidic setup consisted of a fused silica capillary sheathed 
by a needle for sample extraction from a sealed microtiter plate. An aperture oil-immersion 
objective was used to focus the beams to a 1 fl excitation volume within the capillary. Three 
lasers were used in this setup, the two HeNe 633nm (red 1 and 2) and the DPSS 532 nm 
(green). The red 2 laser was focused 12 μm downstream from the red 1 laser and was used to 
determine the flow velocity of the target molecules for cross-correlation (offset 
compensation) of the red 1 and green signals in the time domain. The green laser was 
Hunt et al. Page 4
Anal Biochem. Author manuscript; available in PMC 2016 April 12.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
focused 2 μm downstream from the red 1 laser, to avoid any spectral interference, and was 
used to detect coincident signals from targets bound to both fluorescent probes (excited by 
the red 1 and green lasers). To reduce background noise, free probes were arrested by 
hybridization with specially designed oligonucleotides containing fluorescent quenchers. 
(Figure 3)
Photon bursts were recorded in 1 ms time intervals. The number of time intervals that 
exceeded a certain threshold were compared to three calibration curves prepared from a 
complex Escherichia coli RNA matrix spiked with 1, 2, 5, 10, 25, 50, 75, and 100 pM 
synthetic miRNA. All sequences tested were purchased pre-quantified by Northern blotting, 
and therefore acted as a control for comparison of this method to what is considered the 
current “gold-standard” for miRNA quantification. The results of the direct assay plotted 
against the Northern blotting results had an R2 value of 0.947, demonstrating that the assay 
is in general agreement with the current standard method. The assay had a lower detection 
limit of 15 fg per 1 μg of tissue RNA. The assay was used to profile the expression of 45 
different human miRNAs in 16 different tissues, displaying superb selectivity and versatility.
While the method developed by Neely and colleagues does require the usage of more 
sophisticated and expensive equipment, its ability to characterize and quantify miRNAs in 
conjunction with its versatility to automation makes it a competitive and highly useful assay, 
especially in profiling miRNA expression. Current miRNA expression profiles are carried 
out using microarrays, which are only moderately quantitative. The current standard for 
quantification of miRNAs is Northern blotting, but the huge time requirement and necessity 
for large RNA samples and potentially hazardous radioactive labels make it somewhat 
unsuitable for expression level studies. The method of Neely and colleagues is most 
attractive in its application to profiling studies. The simple procedural nature requires no 
sample enrichment or amplification, and the direct measurements eliminate the need for any 
subsequent clean-up steps. This is a very rapid, sensitive, and highly automatable method.
One of the most prominent biosensors in current research is the molecular beacon, which is 
essentially a highly unique oligonucleotide. Molecular beacons are a relatively new (their 
development was first reported in 1996) technology in bioanalytical fluorescence-based 
detection systems. [20] The beacons are designed as stem-loop DNA oligonucleotide probes 
containing the anti-target sequence flanked by two, usually five nucleotide, self-
complementary sequences. The termini of the probe are conjugated to a fluorescent dye and 
a suitable quencher for that dye. In the absence of target, the flanking sequences anneal 
forming a stem-loop structure and bringing the fluorescent dye and quencher into close 
proximity. When target is present, it anneals to the probe, forcing it into a linear 
conformation, which separates the fluorescent dye and quencher. The benefit of this design 
is that the probe only elicits signal upon direct hybridization to the target sequence, thus 
eliminating the need to remove excess probe prior to taking a measurement. One unique 
approach for the detection and quantification of miRNA developed by Paiboonskuwong and 
colleagues utilized a molecular beacon probe and boasts the ability to solely detect the 
mature form of miRNA. [21] This is achieved by using a fluorescent dye, 4,4-difluoro-5,7-
dimethyl-4-bora-3a,4a-diaza-s-indacene-3-propionic acid (BODIPY® FL), that is 
successfully quenched in the proximity of guanine. The probe is designed such that binding 
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to the precursor form (not yet processed by Dicer) of the miRNA (pre-miRNA) target places 
the fluorescent dye in proximity with a guanine base, quenching its fluorescence. The 
mature miRNA is much shorter, however, and a binding event with this form of the target 
will no longer quench the fluorescent signal. (Figure 4)
This method could be highly useful in profiling cellular expression levels owing to the fact 
that both precursor and mature forms of the miRNA target are present in the cytosol. The 
chosen quenching method affords this unique selection capability, and also places stringent 
implications on the probe design. This molecular beacon is unique in that it does not require 
a conjugated quencher molecule. Instead, the addition of extra guanine beyond the flanking 
sequence will suffice to quench the signal. While this is easy to do, it must also be taken into 
consideration that the probe must be designed such that it hybridizes to the pre-miRNA in a 
location that places the fluorescent dye near a guanine. If this is not possible due to the pre-
miRNA not containing guanine proximal to the targeted sequence, the molecular beacon will 
not be able to distinguish between precursor and mature forms of the target.
The ability to distinguish between the precursor and mature forms of an miRNA sequence is 
undoubtedly very useful. Another fluorescent method which is able to discriminate these 
differences was developed by Allawi and colleagues. [22] The developed assay is an 
application extension of the previously designed Invader mRNA assay. [23; 24] The mRNA 
Invader design utilized a 5′ nuclease (Cleavase) to release a generic 5′ flap from a linear 
probe annealed to the target scaffold but slightly displaced by a second invasive probe 
(Figure 5A). The released flap can then bind to a secondary scaffold and participate in 
another cleavage reaction to produce a fluorescent signal. [24] The small nature of miRNAs 
requires some modifications to the invader and probe oligonucleotides, which are each 
complementary to about half the miRNA target. In this setup, the invader and probe 
oligonucleotides are designed such that they contain self complementary sequences on their 
5′ and 3′ ends, respectively (Figure 5C). These sequences form flanking hairpin structures on 
either side of the miRNA target specific region (TSR). These flanking structures help 
stabilize the miRNA target interaction with the probe system by promoting base stacking, 
and also increase the efficiency of the Cleavase (a structure-specific 5′ nuclease) reaction. 
Release of the probes from the miRNA target is regulated through temperature control. 
Higher temperatures make this exchange more rapid, thus improving enzymatic turnover and 
signal amplification. After cleavage, the assay proceeds just like the mRNA assay. The 
released 5′ flap anneals to a secondary reaction template (SRT) acting as an invasive 
oligonucleotide. The slight overlap of the FRET oligonucleotide causes Cleavase to act in 
the same manner and release the 5′ fluorescent dye (Figure 5B). Now out of close proximity 
of the quencher, the fluorescent signal may be read and quantified.
A calibration curve was prepared from 5 fM to 5 pM samples of synthetic miRNA, and 
assay results were quantified by comparison to this standard curve. The authors report a 
lower detection limit of 20,000 molecules of a single miRNA in a tissue sample size of 50–
100 ng. The let-7a miRNA sequence assay was compared against three other miRNA 
sequences (let-7c, let-7e, and let-7f), each containing a single nucleotide polymorphism. A 
400 fold (or greater) difference in fluorescence signal was observed between the let-7a and 
its polymorphic variants, thereby indicating that this assay can be applied in the detection of 
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SNPs. Additionally, the hairpin structures of the invader and probe oligonucleotides make 
this system sensitive to the distinctive forms of an miRNA sequence. In other words, it is 
able to discriminate between the mature and precursor forms of the target.
The redundant bind and release nature of this assay provides superb signal amplification, 
which affords the benefit of requiring only a small sample size, 50–100 ng, of cellular RNA. 
The more common Northern blotting techniques require a 2–10 μg sample. [25] While the 
optimal temperature for the primary reaction must be determined for each miRNA sequence 
assayed, the procedure is drastically simplified by the fact that secondary reaction conditions 
and probes remain the same in all cases. In other words, the secondary reaction design is 
independent from the primary reaction and therefore remains constant no matter what target 
sequence is selected. Perhaps the only concern with this assay is the variation in results 
when compared to Northern blotting and previous literature reported standards. However, as 
the authors mention, these results are made upon the assumption of total RNA mass per cell. 
If their assumption varied from those made for the standard techniques (i.e. Northern 
blotting or RT-PCR amplification) it would explain the observed variance. In addition to 
being sensitive, and specific, this assay also avoids the use of radioactive labels and can be 
completed in 2–3 h. It is also directly compatible with cellular detergent lysates, making 
sample enrichment and/or amplification unnecessary.
Bioluminescence-Based miRNA Detection
Bioluminescent proteins emit light via a chemical reaction therefore these proteins offer the 
advantage of minimizing background signal by eliminating the use of an external excitation 
light source. The methods described in this section for miRNA detection utilize the 
bioluminescent protein, Renilla luciferase, either alone or as a bioluminescent resonance 
energy transfer (BRET) partner with fluorescent nanoparticles to create competitive assays. 
Renilla luciferase is a 38 kDa protein which, in the presence of the coelenterazine substrate, 
emits bioluminescence at 485 nm. The assays described below have, continued to expand the 
realm of nucleic acid detection/quantification with reported detection levels in the fM range. 
Additionally these assays offer simple one step nucleic acid quantification both in buffer and 
cellular extract, removing many of the additional preparation and isolation steps previously 
required for miRNA detection. As seen for the electrochemical assays described in the 
previous section these also require minimal amounts of total RNA for detection, in the ng or 
μg range.
The work reported by Cissell et al. on nucleic acid detection and quantification utilized a 
BRET based competitive assay. [26] This assay relied upon the signal generated by an 
energy transfer between Renilla luciferase (Rluc) and an acceptor quantum dot (QD705) 
upon nucleic acid hybridization. Rluc was selected as the BRET partner for the QD705 due 
to Rluc’s emission at 485 nm, a good compliment for the 300–500 nm range of the QD 
excitation. The QDs themselves offered advantages to this assay, including high quantum 
yield, large molar extinction coefficient, and photo stability.
For this assay an amine-modified CT1 oligonucleotide probe (5′ 
TCAACATCAGTCTGATAAGCTA-(CH2)6-NH2-3′) corresponding to miR21, was labeled 
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with a carboxy-activated QD705 using 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide 
(EDC) chemistry. The competitive, thiol-modified T1 probe (5′-SH-(CH2)6-
TAGCTTATCAGACTGATGTTGA-3′) was labeled with Rluc via sulfosuccinimidyl 4-(N-
maleimidomethyl)cyclohexane-1-carboxylate (Sulfo-SMCC). The two probes when mixed 
together can hybridize to each other resulting in a measurable signal at 710 nm, in the 
presence of coelenterazine, caused by the energy transfer from the Rluc to the QD705 
(Figure 6). This same system, in the presence of the target nucleic acid, shows a marked 
decrease in emission signal at 710 nm with an increase in the concentration of the target. 
This decrease was measured as a BRET ratio, of the signal at 485 nm to that at 710 nm. To 
create a calibration curve, the concentration of the target nucleic acid was plotted against this 
ratio of the two emission peaks (I485/I710). Luminescent studies on both labeled probes 
showed that the conjugation had no effect on luminescent profiles of the protein or QD. The 
energy transfer from Rluc to QD710 upon adding labeled probes in a cell extract 
demonstrated that the cellular matrix had no effect on the assay, suggesting its application in 
sensing samples without purification or isolation steps.
While this BRET study was designed to detect and quantify nucleic acids, it could easily be 
adapted to specific miRNA studies. The assay as presented here showed detection limits of 4 
pmol (20 nM), within 30 min hybridization. Since this assay is designed as mix and measure 
it demonstrates a simplification over solid phase assays by removing wash steps. 
Additionally the assay is useful for nucleic acid detection in cell extract and does not suffer 
from background interference due to non-specific hybridization.
Further work in the field of miRNA detection and quantification has utilized the 
bioluminescence of proteins, alone, as tags for miRNA detection. One such assay, reported 
by Cissell and colleagues, focused on the use of Rluc as a label in a solid phase competitive 
hybridization assay. [27] Rluc was selected as the tag for this work since it does not require 
an external light source to catalyze the bioluminescence emission, instead relying on the 
chemical reaction with coelenterazine. This increases the signal to noise ratio, allowing for 
highly sensitive miRNA detection. Luciferase tagged miR21 was used in competition with 
untagged “free” miR21 from a total RNA sample. The two miR21 samples, Rluc labeled and 
free, were hybridized in solution to a biotinylated miR21-complementary oligonucleotide 
probe. These hybridized miRNAs were then immobilized onto a neutravidin-coated 
microtiter plate via the biotinylated oligonucleotide probe (Figure 7). The bioluminescence 
of the wells was measured, and the decrease in bioluminescence correlated to the 
concentration of the target, “free”, miRNA via a dose-response curve. This assay was used 
to compare miR21 expression levels from MCF-7 cancer cell lines, which is tumorgenic and 
MCF-10A non-tumorgenic cells.
The work described above, demonstrates a rapid, highly sensitive competitive miRNA 
hybridization assay. Detection limits of 1 fmol were reported for this work, making it 
comparable to the electrochemical methods described in the previous section. The MCF-10A 
cells showed 50 fmol level of miR21, which is comparable to previously reported in vitro 
assays, demonstrating that the cellular extract has no effect on the overall assay. miR21 
spiked samples of MCF-7 were used to determine the accuracy of the above method, with 
97–103% recovery reported. Both of these suggest that there is no non-specific binding from 
Hunt et al. Page 8
Anal Biochem. Author manuscript; available in PMC 2016 April 12.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
other miRNA within the sample. Overall this work offers a simple, expedient assay that 
requires no sample enrichment, which can be used to determine miRNA concentrations in 
crude samples, including saliva and blood. Additionally since this work is done in a micro 
titer plate, it can easily be expanded to high through put work.
Both of these studies offer some advancements over the more often favored optical, Northern 
blotting, or PCR-based quantification methods. They use simple solution and solid phase 
assays that can be used to evaluate crude samples and require only small quantities of total 
RNA for detection of a target. They offer detection limits in the pmol - fmol range, which 
are sensitive enough for expression level studies in total cellular extract. In addition both 
demonstrate selectivity for the target small molecule in a total RNA sample, which 
simplifies the assays by removing isolation and amplification steps, previously required, and 
demonstrates a lack of non-specific binding.
Enzyme-Based miRNA Detection
As demonstrated with the Invader assay approach (which combined fluorescence-based and 
enzyme-based techniques), the utilization of enzymes to generate a reporter signal can 
provide immense signal amplification if substrate turnover is substantial. For the direct or in 
situ detection of miRNAs, enzyme based approaches can be a simple solution to the 
necessity of sample enrichment or amplification procedures. This means higher assay 
sensitivity may be obtained without drastically heightening the procedural complexity.
The enzyme based, colorimetric assay developed by Su and colleagues utilized immobilized 
peptide nucleic acid (PNA) probes to capture target DNA or RNA molecules. [25] While 
their work in RNA detection specifically focused on miRNAs, the assay can theoretically be 
applied to any form of RNA. PNA resembles DNA in structure, but its entire sugar-
phosphate backbone is replaced by a neutral peptide sequence. This neutral charge reduces 
electrostatic repulsions between the capture probe and the target, thus drastically improving 
hybridization. The PNA probe is complementary to the target sequence, terminally 
conjugated to biotin, and immobilized on a streptavidin coated microtiter plate (Figure 8). It 
is a somewhat recent discovery that horseradish peroxidase (HRP) can be absorbed onto 
DNA (or RNA) through electrostatic interaction with the negatively charged sugar-
phosphate backbone. [28] Hybridization of the PNA capture probe to the miRNA target 
spatially localizes the negative charge for HRP adsorption. This unique technique removes 
the need for a target labeling step and thereby increases assay sensitivity. Treatment with 
3,3′,5,5′-tetramethylbenzidine (TMB) and hydrogen peroxide, which are substrates for HRP, 
yields a blue oxidation product that can be further converted to a yellow diamine by 
treatment with strong acid. The absorbance was then read at 450 nm.
A 22 bp PNA probe was used to detect let-7b miRNA in HeLa and A549 lung cancer cells. 
All assays were done on total RNA extractions varying from 1–58 μg. Samples were 
quantified against calibration curves created using varying concentrations (0.1–100 nM) of a 
synthetic 22 bp DNA oligonucleotide. It was determined that the lowest amount of total 
RNA required for this assay was around 2 μg. While the Invader miRNA assay is much more 
sensitive, requiring only 50 ng, the colorimetric assay sample size is still comparable to 
Hunt et al. Page 9
Anal Biochem. Author manuscript; available in PMC 2016 April 12.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Northern blotting techniques. In many ways, the lower sensitivity of this colorimetric 
method is outweighed by its versatility. Not only is the assay rapid, requiring only 1 h of 
incubation for hybridization, and fairly inexpensive, but it can also be adapted to other solid 
support formats such as membranes or glass for microarray or gene profiling applications. 
There are some minor concerns of minimal HRP adsorption to unhybridized PNA capture 
probe, and a variable dependence of HRP adsorption on target length. The authors propose 
valid explanations for these issues, such as increased negative charge due to more phosphate 
groups present on longer targets. However, it appears that the problems have little to no 
effect on the reliability or accuracy of this assay.
The relatively low sensitivity of direct detection methods is commonly overcome through 
the employment of some kind of signal amplification. The novel method developed by 
Hartig and colleagues utilized an intermolecular ribozyme to detect miRNA sequences with 
superior signal amplification. [29] Ribozymes are RNA molecules with special physical 
features that give them catalytic properties. The hairpin ribozyme used in this assay contains 
two helical domains (A and B). The catalytic nature of this type of ribozyme is directly 
related to the conformational flexibility of the overall structure, and cleavage of the external 
substrate nucleotide can only occur upon the docking of the A and B domains. [30] (Figure 
9) The ribozyme setup used by Hartig and colleagues is somewhat special in that a third, 
stem-loop domain (C) has been engineered into the ribozyme such that its conformational 
flexibility can be controlled in the presence or absence of a target sequence (Figure 10). The 
C domain is complementary to the target miRNA sequence and to the substrate binding 
regions of the A domain (termed H1 and H2 in Figure 7), thus restricting conformational 
flexibility by being in a native loop structure in the absence of target and hence preventing 
substrate nucleotide from binding to the A domain. In this case, the substrate is a specially 
designed FRET oligonucleotide. In the presence of target sequence, the C domain becomes 
helical, the substrate binding regions of the A domain become available for substrate 
hybridization, and the docking of domains A and B becomes conformationally permissible, 
which enables the catalytic activity of the ribozyme. The cleavage of the FRET 
oligonucleotide separates the fluorescent dye from the quencher and gives rise to a 
fluorescent signal.
There are several benefits to this ribozyme design strategy. For instance, the intermolecular 
ribozyme design is capable of rapid substrate turnover, which provides an amplification of 
the signal and thereby improves the assay sensitivity. Additionally, the C domain provides 
excellent target specificity. There were a total of nine miRNA sequences from Drosophila 
detected using this assay. There was no noticeable difference in signal output between 
reactions containing only the target sequence and reactions containing the target plus a 
matrix of the other eight miRNA sequences. This stringent discrimination was further 
verified when signal outputs for samples containing either no sequences or the eight non-
target sequences were virtually the same. In order to verify that this assay exhibited higher 
sensitivity than other direct, in situ detection methods, it was compared side by side to a 
molecular beacon assay. In all cases, the ribozyme assay yielded a 20-fold higher signal and 
a much smaller standard deviation than the molecular beacon assay. This is because the 
molecular beacon signal is directly dependent upon the target concentration and lacks any 
signal amplification step. While the signal amplification afforded by the ribozyme approach 
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does give a much better signal to noise ratio, it tends to complicate the use of this assay for 
quantitative measurements. The reaction time and assay conditions must be carefully 
regulated to ensure the substrate turnover rate remains relatively the same for all trials. 
While it is true that the entire ribozyme structure must be synthesized specifically for each 
target, the same FRET oligonucleotide can be used in all cases. One concern with this assay 
is that the ribozyme will always exhibit some small amount of catalytic activity, even in the 
absence of target. However, upon the addition of target the ribozyme reaction rate increases 
10-fold. Therefore, with prompt application of the assay this anomaly will cause negligible 
background noise. Though no lower detection limit was reported for this specific assay, it 
appears by statistical analysis of the plots provided in the supporting information that it is 
sequence dependent and varies from about 3 to 5 nM.
Electrochemical-Based miRNA Detection
Another detection principle employed in quantitative detection of miRNA is based on 
electrochemical measurements. Previous direct electrochemical detection methods, of small 
molecules, have been limited by the low readout signals produced by these systems and the 
poor binding of small oligonucleotide probes to the miRNA. Gao and colleagues, in a series 
of articles, have addressed these issues; these articles employ electrocatalytic moieties to 
enhance the readout from redox reactions upon binding miRNA. Gao’s work has focused on 
designing simple assays, which require very little sample preparation, small amounts of total 
RNA sample, and inexpensive equipment. These assays use electrocatalytic moieties, which, 
under mild conditions, are chemically ligated directly to the miRNA. The attached 
electrocatalytic moieties then assist an oxidation reaction, which is recorded 
amperometrically. Detection limits for these assays have been reported in the femtomolar 
scale, which is comparable to the more common Northern blotting and PCR-based assays.
Two such articles by Gao and colleagues utilized direct chemical ligation to tag miRNAs, in 
a total RNA, with an electrocatalytic moiety. [31; 32] The first of these studies used the 
electrocatalytic properties of an isoniazid-substituted osmium complex, (Os(dmpy)2(IN)Cl+) 
on the oxidation of ascorbic acid (AA). [32] Total RNA samples were extracted from HeLa 
cells. The miRNA within this sample was ligated, via a covalent bond, to 
(Os(dmpy)2(IN)Cl+) through a simple condensation reaction (Figure 11). The ligated and 
tagged miRNA, from the total RNA sample, was extracted via ethanol precipitation. The 
tagged miRNAs were hybridized to complementary oligonucleotide primers immobilized 
onto a gold electrode, and washed. The electro-oxidation current, of the AA, was measured 
in a PBS buffer containing 10 mM AA at 0.15 V. A further series of experiments by Gao and 
colleagues utilizing the same principal focused on the electrocatalytic moiety, Ru(PD)2Cl2 
[PD=1,10-phenanthroline-5,6-dione], to monitor the oxidation of hydrazine. [31] The 
electrocatalytic moiety was attached to the miRNA, again, in a total RNA sample through 
coordinative bonds with the miRNA purine bases. The tagged miRNA was hybridized to 
immobilized complementary oligonucleotides, washed, and the oxidation signal was 
recorded after the addition of hydrazine (Figure 12). Additionally, this work used an indium 
tin oxide (ITO) electrode rather than the gold used for the previously described work.
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The quantitation of the hybridized miRNA in both of these studies was determined by the 
creation of a calibration curve correlating recorded current (μA) to miRNA concentration. In 
order for a linear relationship to be recorded the rate-determining step must be the catalytic 
process. This was achieved by increasing the substrate concentration, which increases the 
mass-transport rates. Additionally, higher electron-transfer rates were achieved by working 
with a more positive applied potential. For these studies, an ideal set of parameters was 
deemed to be 10 mM AA at 0.15 V and 5 mM hydrazine at 0.10 V. The selectivity of the 
assays was also evaluated, each showing clear discrimination between single base-
mismatched miRNA and probe. The recorded current of the AA and hydrazine oxidation 
from tagged let-7b, let-7c, and mir-106 (mir-92 for hydrazine) hybridized to let-7b 
complementary oligonucleotide probes were compared. These showed clear differentiation 
between the complementary and non-complementary miRNAs, including a greater than 75% 
decrease in signal for the let-7c, which has only a single base mismatch with let-7b.
These assays demonstrated a simple, efficient, and low-cost way to quantitatively determine 
the presence of miRNA. Both proved to be ultrasensitive and selective with total RNA 
sample sizes as small as 10 ng, showing an improvement over previous methods which have 
been limited by the need for extensive sample preparation and/or miRNA extension (or 
amplification). Detection limits of 500 femtomolar (using AA) and 0.20 picomolar (using 
hydrazine) have been reported for these assays, offering an improvement over optical 
methods, with much less time. The assays reported here can yield results within hours, post 
extraction the miRNA is reacted with the tag for 3 h and the hybridization to complementary 
probes needs an additional hour. These methods could also easily be adapted to low-density 
electrochemical arrays for miRNA expression profiling. While the authors do state that the 
total miRNA recovered from the cell extract was quantified for both assays by UV-Vis 
neither article gives any indication of the efficiency of their extraction protocols. 
Additionally the authors are less than clear about the efficiency of their tagging method, 
stating that gel electrophoresis indicated that the miRNA was tagged but not how complete 
this tagging was.
Further work by Gao and colleagues continued to focus on electrochemical detection of 
miRNA, however this work utilized electrocatalytic nanoparticle tags rather than chemical 
moieties used for the previous studies. [33] For this work OsO2 nanoparticles, which 
catalyze the oxidation of hydrazine, were attached to the miRNAs following their 
hybridization to immobilized capture probes, on an ITO electrode. Immobilized 
oligonucleotide probes were incubated with the total RNA from extracted HeLa cells to 
allow the miRNA to hybridize to the probes. The hybridized miRNA was reacted with OsO2 
nanoparticles, in a hydrazine buffer, and washed with buffer to remove any unbound OsO2, 
and the oxidation potential of the hydrazine recorded. The nanoparticles were chemically 
ligated to the miRNA through a condensation reaction between isoniazid molecules, grafted 
onto the nanoparticles, and the 3′-end dialdhydes of the miRNA (Figure 13). As described 
for the previous studies, mass-transport and electron transfer parameters were evaluated and 
an ideal set of conditions determined, −0.10 V and 30 mM hydrazine in PBS buffer. Once 
these parameters had been stabilized, the read out potential was directly correlated to the 
concentration of the hybridized miRNA.
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The assay reported a linear relationship between current and concentration from 0.3 – 200 
pM miRNA with a measureable signal reported for as low as 80 fM miRNA. The specificity 
of the assay was evaluated by comparison of the amperometric readings of let-7b, mir-106, 
and mir-139 hybridized to let-7b complementary probes. Additionally, comparison between 
let-7b and let-7c, showed that the assay can easily distinguish between a single base 
mismatch, with a signal detected for fully matched miRNA and less than 25% signal 
reported for mismatched miRNA. These results are comparable to the previous 
electrochemical work by this group, and offer many of the same advantages over more 
conventional methods, such as PCR-based and Northern blot techniques. The use of these 
nanoparticles, over the electrocatalytic moieties presented previously in this section offer 
additional advantages for the electrocatalytic quantification of miRNA. These advantages 
include control over the choice of the capping groups on the nanoparticle, which simplifies 
their ligation to the miRNA and the improved catalytic effect on the oxidation of the 
hydrazine that results in improved signal. However the authors do not address the efficiency 
and reliability of the conjugation of the nanoparticle tag to the miRNA.
An electrochemical assay was developed by Fan and colleagues, which utilized conducting 
polymer nanowires for miRNA quantification. [34] For this work PNA capture probes were 
immobilized onto a nano-gapped biosensor array made up of 100 pairs of interlocking 
comb-like microelectrodes. These electrodes have 150–200 fingers, each 700 nm wide and 
200 μm long, and separated by a 300 nm gap. These fingers allow for simple multiplexing, if 
different probes were immobilized on each. A total RNA sample from Hela and lung cancer 
cells was hybridized to these capture probes, creating a net negative charge. The hybridized 
miRNA were then incubated with a mixture of aniline/HRP/H2O2 at pH 4.0, the protonated 
aniline molecules align around the negatively charged, hybridized miRNA, forming 
polyaniline polymers. These conducting polymer polyaniline (PAn) nanowires were then 
expanded, by doping with HCl vapors, creating an electrically conducting network bridging 
the gaps of the biosensor array (Figure 14). Since the total deposition of these nanowires, 
and their electrically conducting network, is dependent upon the amount of hybridized 
miRNA, a calibration curve was created correlating the recorded conductance to the 
concentration of miRNA present.
The assay showed a dynamic range from 20 pM to 10 fM and a detection limit of 5.0 fM, 
which is more sensitive than the previously reported electrocatalytic methods of Gao and 
colleagues. The selectivity of this assay was examined, by comparing the output of perfectly 
matched and single base mismatched miRNAs, let-7b and let-7c respectively; with let-7b 
capture probes. As seen for the previous assays reported by Gao et al., the single 
polymorphism of let-7c can easily be discriminated, however this assay showed an even 
greater signal increase of 20:1 for let-7b over let-7c. Finally the blank sample, without target 
miRNA, demonstrated that the non-hybridization related signal is extremely low. While this 
assay offers many advantages over the previously discussed electrochemical methods, the 
major improvement is due to the PNA capture probes. These probes have a much higher 
affinity for miRNA, due to the absence of repulsion, normally caused by electrostatic 
charges along the backbones of the probe and the miRNA. Additionally, the neutral 
backbone of these probes prevents adsorption of the PAn, decreasing the background noise.
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The work described above by Gao and Fan offers many advantages over optical detection 
methods. These methods yield sensitive and selective results on a scale not previously seen 
for electrochemical detection. Gao and Fan have demonstrated detection limits in the fM 
range, which can be obtained with as little as 10 ng of total RNA. These detection limits 
showed a three orders of magnitude sensitivity improvement over direct voltammetry. 
Expression level studies indicated good agreement with the more common Northern 
blotting, while being more efficient and more sensitive. These also offer the advantage of 
requiring mostly inexpensive simple electronics, little to no sample preparation, and smaller 
samples. Since most of these methods label the miRNA itself rather than the oligonucleotide 
probe, and these attachments are made under mild conditions, the issues seen previously 
with labeling short sequences is reduced. A further improvement is the labeling of the target 
post hybridization, to prevent the label/tag from interfering with the hybridization.
Summary
In this review we have covered several unique miRNA detection and quantification 
techniques that may be applied to direct or in situ screening assays. While these novel 
designs hold immense promise for the future of miRNA detection, there are still several 
issues which must be addressed before they are accepted among the current standard PCR or 
Northern blotting methods. Generally, the methods must be more adaptable. For instance, 
the molecular beacon design by Paiboonskuwong is currently limited to miRNA targets that 
are flanked by guanines in their primary transcripts. Without the guanine in appropriate 
proximity to the quencher, detection is not limited to the mature form of the target. In the 
methods developed by Gao and Fan, the efficiency of tagging of miRNAs with 
electrocatalytic moieties and nanoparticles must be further evaluated before their methods 
can be considered mainstream. Of equal concern is that many of the methods described in 
this review are not adaptable to multiplex miRNA detection platforms, which is essential for 
miRNA expression profiling. While many of the discussed assays demonstrated exceptional 
adaptability, the assay developed by Neely for instance (which tested 45 human miRNAs in 
16 different tissues), the robustness of these methods must be further explored before they 
can be used as standard procedures. This is especially true of the solution phase assays, 
which may be applied directly to a variety of complex matrices and hopefully display 
acceptable background tolerance. These are the kinds of challenges the discussed assays will 
face as they are further developed.
As we continue to discover the vast impact that miRNAs have on the course of diseases, 
such as cancer, and the immense promise they hold in the area of gene therapy, rapid and 
sensitive methods for their direct detection and quantification are of utmost importance. A 
simple approach to direct detection is to monitor some type of hybridization event. However, 
the small size and low in situ concentration of miRNA molecules typically foist signal or 
target amplification as a prerequisite and make the direct detection approach less viable 
through procedural complication. To address these problems, novel techniques have been 
developed which employ one or more of the following: signal amplification through enzyme 
substrate turnover, highly favorable hybridization conditions using LNA or PNA capture 
probes, highly sensitive forms of spectroscopy such as FCS or bioluminescence, optimized 
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reporter molecules such as gold nanoparticles, or highly attuned and responsive 
electrocatalytic/amperometric monitoring.
These discussed methods stand out above the rest because they have achieved comparable or 
improved sensitivity and specificity with respect to the current “gold standards” without the 
necessity for potentially hazardous materials, such as radioactive labels or toxic dyes, and 
highly expensive imaging equipment. These factors are becoming increasingly important in 
today’s environmentally conscious society, and by drastically reducing the procedural 
complexity and overall expense of such assays, it opens the doors to academic environments 
making research in the field of miRNAs much more accessible.
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Figure 1. 
The genes coding for the primary miRNA transcript are typically found in intergenic regions 
or within the introns of eukaryotic protein-coding genes. The primary transcript is further 
processed and capped for nuclear export to the cytoplasm where the precursor form is 
cleaved into the 18–24 nucleotide mature sequence, which is incorporated into the RISC 
protein complex. Figure adapted from Macmillan Publishers Ltd: H. Grosshans, and W. 
Filipowicz, Molecular biology: the expanding world of small RNAs. Nature 451 (2008) 
414–6.
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Figure 2. 
In the colorimetric assay designed by Yang and colleagues, the functionalized gold 
nanoparticle binds adjacent to the biotinylated probe on the miRNA target, thus allowing it 
to be immobilized on a streptavidin coated plate. The grayscale absorbance from the silver 
enhancement is used for colorimetric quantification of target. Figure adapted from Elsevier 
B.V.: W.J. Yang, X.B. Li, et al., Quantification of microRNA by gold nanoparticle probes. 
Analytical Biochemistry 376 (2008) 183–8.
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Figure 3. 
In the FCS based assay developed by Neely and colleagues, free probes were sequestered by 
specially designed quenching probes. The red 2 laser was used to correlate the red 1 and 
green signals. Reprinted by permission from Macmillan Publishers Ltd: L. Neely, S. Patel, et 
al., A single-molecule method for the quantitation of microRNA gene expression. Nat Meth 
3 (2006) 41–6.
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Figure 4. 
In the molecular beacon assay developed by Paiboonskuwong, adjacent guanine in the 
primary and precursor forms of the target successfully quenches the fluorophore and limits 
signal production to the mature form only. Reprinted by permission from Oxford University 
Press: K. Paiboonskuwong, and Y. Kato, Detection of the mature, but not precursor, RNA 
using a fluorescent DNA probe. Nucleic Acids Symposium Series (2006) 327–8.
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Figure 5. 
(A) The miRNA Invader assay developed by Allawi and colleagues is based on the same 
principles as the RNA Invader assay. (B) A general FRET oligo may be used for all 
sequences as it anneals to the SRT. (C) Self-complementary adaptations must be made to the 
invasive and probe oligos to compensate for the small size of the miRNA target. Reprinted 
by permission from the RNA Society: H.T. Allawi, J.E. Dahlberg, et al., Quantitation of 
microRNAs using a modified Invader assay. RNA 10 (2004) 1153–61.
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Figure 6. 
In the absence of the target, utilized in the BRET-based assay developed by Cissell et al., the 
Rluc-probe and the QD-probe hybridize creating a BRET signal. In the presence of the 
target, there is a competition between the target and the Rluc-probe, decreasing the BRET 
signal. With kind permission from Springer Science+Business Media: Bioanal Chem, Rapid 
single-step nucleic acid detection, 319, 2008, 2577, K.A. Cissell, Y. Rahimi, S. Shrestha, 
E.A. Hunt, and S.K. Deo, fig. 1.
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Figure 7. 
The miRNA (both labeled and unlabeled) hybridize to the biotinylated probe, in the solid 
phase assay described by Cissell et al. The hybridized probe is immobilized onto a 
neutravidin plate, washed to remove unbound miRNA, and the emission signal recorded. 
Figure adapted from the American Chemical Society: K.A. Cissell, Y. Rahimi, et al., 
Bioluminescence-based detection of microRNA mir21 in breast cancer cells. Anal Chem 80 
(2008) 2319–25.
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Figure 8. 
In the enzymatic/colorimetric assay developed by Su and colleagues, the PNA capture probe 
improves hybridization conditions and localizes negative charge for HRP adsorption. 
Reprinted by permission from the American Chemical Society: X. Su, H.F. Teh, et al., 
Enzyme-based colorimetric detection of nucleic acids using peptide nucleic acid-
immobilized microwell plates. Anal Chem 79 (2007) 7192–7.
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Figure 9. 
The catalytic activity of a ribozyme is directly related to its structural conformation. 
Reprinted by permission from Elsevier B.V.: M.J. Fedor, Structure and function of the 
hairpin ribozyme. J Mol Biol 297 (2000) 269–91.
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Figure 10. 
In the ribozyme based assay developed by Hartig and colleagues, the stem-loop domain (C) 
prevents cleavage of the FRET oligo when not bound to target by restricting the ribozyme to 
an inactive conformation and blocking the substrate binding domain (A). Figure adapted 
from the American Chemical Society: J.S. Hartig, I. Grüne, et al., Sequence-specific 
detection of microRNAs by signal-amplifying ribozymes. J Am Chem Soc 126 (2004) 722–
3.
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Figure 11. 
In the electrochemical method developed by Gao et al, the miRNA was ligated, via a 
covalent bond, to (Os(dmpy)2(IN)Cl+) through a simple condensation reaction. Figure 
adapted from Elsevier B.V.: Z. Gao, and Y.H. Yu, A microRNA biosensor based on direct 
chemical ligation and electrochemically amplified detection. Sensors and Actuators B: 
Chemical 121 (2007) 552–9.
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Figure 12. 
For the electrochemical work by Gao et al., the labeled miRNA was hybridized to the 
immobilized probes; the oxidation signal was recorded upon the addition of hydrazine. 
Figure adapted from Elsevier B.V.: Z. Gao, and Y.H. Yu, Direct labeling microRNA with an 
electrocatalytic moiety and its application in ultrasensitive microRNA assays. Biosensors 
and Bioelectronics 22 (2007) 933–40.
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Figure 13. 
Nanoparticles were chemically ligated to the hybridized miRNAs, in the electrocatalytic 
assays developed by Gao et al., through a condensation reaction. Reprinted by permission 
from the American Chemical Society: Z. Gao, and Z. Yang, Detection of microRNAs using 
electrocatalytic nanoparticle tags. Anal Chem 78 (2006) 1470–7.
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Figure 14. 
For the electrochemical assay developed by Fan and colleagues, the total RNA sample was 
hybridized to the capture probes, creating a net negative charge. The hybridized miRNA was 
then incubated with an aniline mixture. The protonated aniline molecules align around the 
hybridized miRNA forming polyaniline polymers. The nanowires were then expanded by 
doping with HCl vapors, creating an electrically conducting network bridging the gaps of the 
biosensor array. Reprinted by permission from the American Chemical Society: Y. Fan, X. 
Chen, et al., Detection of microRNAs using target-guided formation of conducting polymer 
nanowires in nanogaps. J Am Chem Soc 129 (2007) 5437–43.
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